financetom
Business
financetom
/
Business
/
Vontier Shares Down After Q1 Sales Fall, Full-Year Sales Guidance Cut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vontier Shares Down After Q1 Sales Fall, Full-Year Sales Guidance Cut
May 2, 2024 7:30 AM

10:13 AM EDT, 05/02/2024 (MT Newswires) -- Vontier ( VNT ) shares fell nearly 4% in recent Thursday trading after the company reported lower sales in Q1 and cut its full-year sales guidance.

The company reported Q1 adjusted earnings earlier Thursday of $0.74 per diluted share, up from $0.68 a year earlier.

Analysts surveyed by Capital IQ expected $0.70.

Sales for the quarter ended March 29 was $755.8 million, down from $776.4 million a year earlier.

Analysts surveyed by Capital IQ expected $755.1 million.

The company said it expects Q2 adjusted EPS of $0.67 to $0.71. Analysts surveyed by Capital IQ expect $0.73. Sales for the quarter are expected to be $735 million to $750 million, the company said. Analysts surveyed by Capital IQ expect $762.2 million.

Vontier ( VNT ) maintained its full-year 2024 adjusted EPS guidance of $3 to $3.15. Analysts surveyed by Capital IQ expect $3.12. The company expects sales for the year of $3.04 billion to $3.10 billion, compared with its prior outlook of $3.05 billion to $3.11 billion. Analysts surveyed by Capital IQ expect $3.12 billion.

Price: 39.00, Change: -1.62, Percent Change: -3.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Immunic Shares Advance on Positive Outcome From Interim Analysis of Potential MS Treatment
Immunic Shares Advance on Positive Outcome From Interim Analysis of Potential MS Treatment
Oct 22, 2024
08:09 AM EDT, 10/22/2024 (MT Newswires) -- Immunic ( IMUX ) shares rose more than 14% in premarket trading after it reported positive outcomes from an interim analysis of its phase 3 trial of vidofludimus calcium for the treatment of relapsing multiple sclerosis. Based on the interim analysis, an independent data monitoring committee has recommended that the trials should continue...
Exclusive-Carlyle drops out of bidding process for Thyssenkrupp marine unit
Exclusive-Carlyle drops out of bidding process for Thyssenkrupp marine unit
Oct 22, 2024
FRANKFURT (Reuters) -Carlyle has dropped out of an ongoing bidding process for the warship division of stricken conglomerate Thyssenkrupp, the German company said on Tuesday. We can confirm that the investment company Carlyle Group ( CG ) has informed us that it is withdrawing from the bidding process for the investment in Thyssenkrupp's marine division, Thyssenkrupp said in a response...
Hyzon Motors to Deliver 12 Fuel Cell Electric Vehicles to GreenWaste
Hyzon Motors to Deliver 12 Fuel Cell Electric Vehicles to GreenWaste
Oct 22, 2024
08:09 AM EDT, 10/22/2024 (MT Newswires) -- Hyzon Motors ( HYZN ) said Tuesday that it has received an order from GreenWaste to deliver 12 hydrogen-powered refuse fuel cell electric vehicles, or FCEVs. Hyzon Motors ( HYZN ) said its FCEVs will help GreenWaste achieve its goal of reducing combined Scope 1 and Scope 2 greenhouse gas emissions by 45%...
Lithium Ionic Initiates Engineering, Construction Management Services Contracts for Bandeira Project in Brazil
Lithium Ionic Initiates Engineering, Construction Management Services Contracts for Bandeira Project in Brazil
Oct 22, 2024
08:14 AM EDT, 10/22/2024 (MT Newswires) -- Lithium Ionic ( LTHCF ) said Tuesday that it initiated engineering, procurement and construction management services for its flagship Bandeira lithium project in Brazil. The company said the milestone marks the transition to the construction and development phase of the project and is a key step towards production. Lithium Ionic ( LTHCF )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved